Low dose endotoxin priming is accountable for coagulation abnormalities and organ damage observed in the Shwartzman reaction. A comparison between a single-dose endotoxemia model and a double-hit endotoxin-induced Shwartzman reaction

Thrombosis Journal

Volumn 4, Issue , 2006, Pages

  Slofstra, Sjoukje H ^a   ten Cate, Hugo ^b   Spek, C Arnold ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING DISORDER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE MODEL; DISSEMINATED INTRAVASCULAR CLOTTING; ENDOTOXEMIA; FEMALE; INNATE IMMUNITY; LIVER DISEASE; LUNG EMBOLISM; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; SEPSIS; SHWARTZMAN PHENOMENON; THROMBOSIS;

EID: 33748765793     PISSN: 14779560     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-4-13     Document Type: Article

References (24)

1. Astiz ME, Rackow EC: Septic shock. Lancet 1998, 351:1501-1505.
2. Levi M, Ten Cate H: Disseminated intravascular coagulation. New England Journal of Medicine 1999, 341:586-592.
3. Norman KE, Cotter MJ, Stewart JB, Abbitt KB, Ali M, Wagner BE, Wallace WA, Forlow SB, Hellewell PG: Combined anticoagulant and antiselectin treatments prevent lethal intravascular coagulation. Blood 2003, 101:921-928.
4. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJJ, Recombinant human protein CWESS: Efficacy and safety of recombinant human activated protein C for severe sepsis. [comment]. New England Journal of Medicine 2001, 344:699-709.
5. Taylor FBJ, Toh CH, Hoots WK, Wada H, Levi M: Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost 2001, 86:1327-1330.
6. Dhainaut JF, Yan SB, Joyce DE, Pettila V, Basson B, Brandt JT, Sundin DP, Levi M: Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation. J Thromb Haemost 2004, 2:1924-1933.
7. Warren BL, Eid A, Singer P, Pillay SS, Carl P, Novak I, Chalupa P, Atherstone A, Penzes I, Kubler A, Knaub S, Keinecke HO, Heinrichs H, Schindel F, Juers M, Bone RC, Opal SM: Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial. Jama 2001, 286:1869-1878.
8. Abraham E, Reinhart K, Svoboda P, Seibert A, Olthoff D, Dal Nogare A, Postier R, Hempelmann G, Butler T, Martin E, Zwingelstein C, Percell S, Shu V, Leighton A, Creasey AA: Assessment of the safety of recombinant tissue factor pathway inhibitor in patients with severe sepsis: a multicenter, randomized, placebo-controlled, single-blind, dose escalation study. Crit Care Med 2001, 29:2081-2089.
9. Abraham E, Reinhart K, Opal S, Demeyer I, Doig C, Rodriguez AL, Beale R, Svoboda P, Laterre PF, Simon S, Light B, Spapen H, Stone J, Seibert A, Peckelsen C, De Deyne C, Postier R, Pettila V, Artigas A, Percell SR, Shu V, Zwingelstein C, Tobias J, Poole L, Stolzenbach JC, Creasey AA: Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial. Jama 2003, 290:238-247.
10. Camerer E, Cornelissen I, Kataoka H, Duong DN, Zheng YW, Coughlin SR: Roles of protease-activated receptors in a mouse model of endotoxemia. Blood 2006, 107:3912-3921.
11. Schoenmakers SH, Versteeg HH, Groot AP, Reitsma PH, Spek CA: Tissue factor haploinsufficiency during endotoxin induced coagulation and inflammation in mice. J Thromb Haemost 2004, 2:2185-2193.
12. Corral J, Yelamos J, Hernandez-Espinosa D, Monreal Y, Mota R, Arcas I, Minano A, Parrilla P, Vicente V: Role of lipopolysaccharide and cecal ligation and puncture on blood coagulation and inflammation in sensitive and resistant mice models. Am J Pathol 2005, 166:1089-1098.
13. Slofstra SH, Spek CA, ten Cate H: Disseminated intravascular coagulation. Hematol J 2003, 4:295-302.
14. Thomas L, Good RA: Studies on the Generalized Shwartzman Reaction. I. General observations concerning the phenomenon. J Exp Med 1952, 96:605-624.
15. Lee SY, Chang SK, Lee IH, Kim YM, Chung SI: Depletion of plasma factor XIII prevents disseminated intravascular coagulation-induced organ damage. Thromb Haemost 2001, 85:464-469.
16. Koide N, Abe K, Narita K, Kato Y, Sugiyama T, Jiang GZ, Yokochi T: Apoptotic cell death of vascular endothelial cells and renal tubular cells in the generalized Shwartzman reaction. FEMS Immunology & Medical Microbiology 1996, 16:205-211.
17. Koide N, Narita K, Kato Y, Sugiyama T, Chakravortty D, Morikawa A, Yoshida T, Yokochi T: Expression of Fas and Fas ligand on mouse renal tubular epithelial cells in the generalized shwartzman reaction and its relationship to apoptosis. Infect Immun 1999, 67:4112-4118.
18. Kim S, Iizuka K, Aguila HL, Weissman IL, Yokoyama WM: In vivo natural killer cell activities revealed by natural killer cell-deficient mice. Proc Natl Acad Sci U S A 2000, 97:2731-2736.
19. Asakura H, Suga Y, Aoshima K, Ontachi Y, Mizutani T, Kato M, Saito M, Morishita E, Yamazaki M, Takami A, Miyamoto K, Nakao S: Marked difference in pathophysiology between tissue factor-and lipopolysaccharide-induced disseminated intravascular coagulation models in rats. Crit Care Med 2002, 30:161-164.
20. Hermida J, Montes R, Munoz MC, Orbe J, Paramo JA, Rocha E: Effects of low molecular weight heparin, alone or combined with antithrombin III, on mortality, fibrin deposits and hemostatic parameters in endotoxin-induced disseminated intravascular coagulation in rabbits. Am J Hematol 1999, 60:6-11.
21. Dieli F, Sireci G, Russo D, Taniguchi M, Ivanyi J, Fernandez C, Troye-Blomberg M, De Leo G, Salerno A: Resistance of natural killer T cell-deficient mice to systemic Shwartzman reaction. J Exp Med 2000, 192:1645-1652.
22. Cerra FB: Hypermetabolism, organ failure, and metabolic support. Surgery 1987, 101:1-14.
23. West MA, Heagy W: Endotoxin tolerance: a review. Crit Care Med 2002, 30:S64-73.
24. Brozna JP: Shwartzman reaction. Semin Thromb Hemost 1990, 16:326-332.